You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-22. Secondary drugs cited by clients entering treatment, 2010 or most recent year available
Part (i) Outpatient units
| Secondary drug | Number of citations by all clients | % |
|---|---|---|
| Volatile Inhalants | 919 | 0.3% |
| Hallucinogens | 2879 | 1.0% |
| Other Substances | 10546 | 3.7% |
| Stimulants | 15907 | 5.5% |
| Hypotics and Sedatives | 20048 | 7.0% |
| Opiates | 22797 | 7.9% |
| Cocaine | 55989 | 19.5% |
| Alcohol | 71780 | 24.9% |
| Cannabis | 86956 | 30.2% |
| Total number of citations | 287821 | 100% |
Notes
The countries supplying data are: BE, BG, CZ, DK, DE, IE, GR, EE, ES, FR, IT, CY, LV, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, HR, UK.
The number of treatment clients in each country is listed in Table TDI-7.
See also 'General notes for interpreting data’ on the Explanatory notes and help page.
Source:
Reitox national reports 2011 — Table TDI by centre type.